BPMX - BioPharmX Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Apr 2019)Next Qtr. (Jul 2019)Current Year (2020)Next Year (2021)
No. of Analysts2222
Avg. Estimate-0.26-0.25-1.05-1.05
Low Estimate-0.27-0.26-1.1-1.36
High Estimate-0.25-0.25-1-0.75
Year Ago EPS-0.5-0.5-2-1.05
Revenue EstimateCurrent Qtr. (Apr 2019)Next Qtr. (Jul 2019)Current Year (2020)Next Year (2021)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales18k24k57kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History4/29/20187/30/201810/30/20181/30/2019
EPS Est.-0.62-0.5-0.5-0.5
EPS Actual-0.5-0.5-0.5-0.25
Difference0.12000.25
Surprise %19.40%0.00%0.00%50.00%
EPS TrendCurrent Qtr. (Apr 2019)Next Qtr. (Jul 2019)Current Year (2020)Next Year (2021)
Current Estimate-0.26-0.25-1.05-1.05
7 Days Ago-0.26-0.25-1.05-1.05
30 Days Ago-0.25-0.25-1.25-1.05
60 Days Ago-0.01-0.01-0.05-0.05
90 Days Ago00-0.09-0.06
EPS RevisionsCurrent Qtr. (Apr 2019)Next Qtr. (Jul 2019)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBPMXIndustrySectorS&P 500
Current Qtr.48.00%N/AN/A0.02
Next Qtr.50.00%N/AN/A0.04
Current Year47.50%N/AN/A0.05
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A